Skip to main content

Specialized Cell-Free DNA Blood Collection Tubes Can Be Repurposed for Extracellular Vesicle Isolation: A Pilot Study.

Heatlie J, Chang V, Fitzgerald S, Nursalim Y, Parker K, Lawrence B, Print CG, Blenkiron C

Publication: Biopreserv Biobank (2020)PMID: 32856938View on PubMed

Purpose

The purpose of this paper was to investigate the effects of collection tube type and delayed processing on hemolysis, extracellular vesicle (EV) counts, and protein levels in microEVs from the plasma pellet and nanoparticle EVs (nanoEVs) obtained from plasma using size-exclusion chromatography (SEC).

Conclusion

Hemolysis in plasma was found to increase when blood was stored in EDTA or Roche tubes for 3 days before processing but was unaffected by storage of blood in Streck tubes. NanoEV counts were comparable between tubes types and timepoints but differed among the three patients. In contrast, the protein content of the nanoEV (Fractions 8 and 9) increased non-significantly with storage particularly in Roche and EDTA tubes. Further investigation of the nanoEVs showed that when blood was stored for 3 versus 0 days, the platelet protein CD61 increased significantly regardless of tube type, the leukocyte marker CD45 increased in blood stored in EDTA tubes, and the red blood cell marker CD235a increased non-significantly in all tube types. Interestingly, microEV counts in the plasma pellet increased when blood was stored in Streck or Roche tubes for 3 days and the corresponding protein content was increased in all three tube types. Dot blot analysis revealed that storage of blood for three days resulted in decreases in the platelet protein CD61 in the microEV pellet in Roche tubes and increased red blood cell marker CD235a in specimens stored in Streck tubes.

Studies (1)

Purpose

The purpose of this study was to investigate the effects of collection tube type and delayed processing on hemolysis, extracellular vesicle (EV) counts, and protein levels in microEVs from the plasma pellet and nanoEVs obtained from plasma using size-exclusion chromatography (SEC). Peripheral blood was from three healthy non-fasting donors was collected using a 21-gauge needle into K3EDTA BD Vacutainer tubes, Streck Cell-Free DNA BCT, and Roche Cell-Free DNA Blood Collection Tubes.  Plasma was obtained by centrifugation at 1500 x g for 10 min with slow braking followed by 10,000 x g for 10 min within 1 h and 3 days after blood collection and frozen at -80°C. The 10,000 x g pellet was stored for microparticle EV analysis. NanoEVs were isolated from plasma using qEV2 size exclusion column and eluted in 20 fractions. NanoEV morphology was investigated by transmission electron microcopy using fractions 8 and 9. NanoEV size and count were evaluated using nanoparticle tracking analysis of pooled fractions 8 and 9. Protein concentrations were determined in the plasma pellet, fraction 8/9, and fraction 17 using the BCA assay. Proteins were blotted on membranes and stained with antibodies to CD61, EpCAM, CD45, and CD235a and densitometry of the spots was analyzed. Hemolysis in the plasma was analyzed spectrophotometrically.

Summary of Findings

Hemolysis in plasma was found to increase when blood was stored in EDTA or Roche tubes for 3 days before processing but was unaffected by storage of blood in Streck tubes. NanoEVs had a size peak at 100 nm and were found predominantly in the size exclusion chromatography fractions 8 and 9. The highest protein levels and lowest levels of nanoEVs were found in fraction 17. NanoEV counts were comparable between tube types and timepoints and instead differed among the three patients. In contrast, the protein content of the nanoEV (Fractions 8 and 9) increased non-significantly with storage, particularly in Roche and EDTA tubes, and the protein fraction (17) had non-significant increased protein content in EDTA tubes and non-significant decreases in Roche or EDTA. Further investigation of the nanoEVs (fractions 8/9) showed that when blood was stored for 3 versus 0 days, the platelet protein CD61 increased significantly regardless of tube type (P<0.05 for EDTA, P<0.01 for Roche, and P<0.001 for Streck), the leukocyte marker CD45 increased in blood stored in EDTA tubes (P<0.05), and the red blood cell marker CD235a increased non-significantly. Interestingly, microEV counts in the plasma pellet increased when blood was stored in Streck or Roche tubes for 3 days (P<0.01) and the corresponding protein content was increased in all three tube types (P<0.001 EDTA and P<0.01 Streck and Roche). Dot blot analysis revealed high levels of the platelet protein CD61 in the microEV pellet processed immediately and that these levels decreased when blood was stored in Roche tubes for 3 days (P<0.05). The only other marker significantly affected by delayed processing in the microEV pellet was increased red blood cell marker CD235a in specimens stored in Streck tubes (P<0.01).

  • Biospecimens

    FluidBlood
    FluidPlasma
  • Preservation Types

    None (Fresh)Other PreservativeStreck/BCT
  • Diagnoses

    Normal
  • Platforms

    ProteinImmunoassay
    ProteinColorimetric assay
    MorphologySpectrophotometry
    Cell count/volumeLight scattering
    Cell count/volumeElectron microscopy
    MorphologyElectron microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionType of collection container/solution
    K3-EDTA BD Vacutainer tubes
    Roche Cell-Free DNA Blood Collection
    Streck Cell-Free DNA BCT
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    StorageStorage duration
    0 days
    3 days
    Immunoassay SpecificTargeted peptide/protein
    CD235a
    CD45
    CD61
    EpCam